Tekla Life Sciences Investors
HQL• NYSE
$19.84
+0.11+0.56%
In the past 24 hours
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: September 2025 · 2025-09-30
Revenue
$11.63M
Net income
$132.83M
Free cash flow
-$1.28M
Diluted EPS
—
Gross margin
78.99%
Profit margin
1141.76%
Assets
$515.38M
Cash
$75.54K
Valuation
Market Cap$553.12M
Enterprise Value$538.32M
PE (TTM)3.35
PE (Fwd)0.00
Price to Sales285.35
EV / EBITDA0.00
Price to Book1.12
PEG Ratio0.00
Cash Flow
FCF Yield—
FCF / Share-$0.08
SBC-Adj FCF Yield—
SBC-Adj FCF / Share-$0.08
SBC Impact—
Margins & Growth
Gross Margin100.00%
Operating Margin99.08%
Profit Margin505.41%
Quarterly Rev YoY+463.30%
Quarterly EPS YoY+164.30%
Balance
Cash$75.54K
Debt$9.33K
Net Debt-$75.54K
Current Ratio1.74
Debt / Equity—
Dividend
Dividend Yield10.14%
Payout Ratio—
DPS (TTM)$2.24
Last Ex-Date2026-02-20
Dividend history
Cash dividends by ex-date, not an investment recommendation.
Trailing 12 months
$1.48
Latest dividend
$0.56 · Feb 20, 2026
First record
Nov 14, 1996
Next ex-date
—
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Feb 20, 2026 | $0.56 | Mar 31, 2026 | Quarterly |
| Nov 21, 2025 | $0.50 | Jan 12, 2026 | Quarterly |
| Aug 22, 2025 | $0.42 | Sep 30, 2025 | Quarterly |
| May 22, 2025 | $0.43 | Jun 30, 2025 | Quarterly |
| Feb 21, 2025 | $0.47 | Mar 31, 2025 | Quarterly |
| Nov 21, 2024 | $0.50 | Jan 10, 2025 | Quarterly |
| Aug 23, 2024 | $0.49 | Sep 30, 2024 | Quarterly |
| May 22, 2024 | $0.48 | Jun 28, 2024 | Quarterly |
| Feb 21, 2024 | $0.39 | Mar 28, 2024 | Quarterly |
| Nov 21, 2023 | $0.30 | Jan 10, 2024 | Quarterly |
| Aug 24, 2023 | $0.32 | Sep 29, 2023 | Quarterly |
| May 24, 2023 | $0.32 | Jun 30, 2023 | Quarterly |
| Feb 24, 2023 | $0.33 | Mar 31, 2023 | Quarterly |
| Nov 23, 2022 | $0.31 | Dec 30, 2022 | Quarterly |
| Aug 25, 2022 | $0.31 | Sep 30, 2022 | Quarterly |
| May 26, 2022 | $0.35 | Jun 30, 2022 | Quarterly |
| Feb 24, 2022 | $0.39 | Mar 31, 2022 | Quarterly |
| Nov 23, 2021 | $0.42 | Dec 31, 2021 | Quarterly |
| Aug 26, 2021 | $0.43 | Sep 30, 2021 | Quarterly |
| May 27, 2021 | $0.41 | Jun 30, 2021 | Quarterly |
| Feb 25, 2021 | $0.43 | Mar 31, 2021 | Quarterly |
| Dec 30, 2020 | $0.02 | Jan 6, 2021 | Other |
| Nov 25, 2020 | $0.40 | Dec 31, 2020 | Quarterly |
| Aug 27, 2020 | $0.41 | Sep 30, 2020 | Quarterly |
Price
+48.72%
Jul 19, 2021 - May 8, 2026 · 1,208 daily points
Revenue
↑ 1205.0%Net Income
↑ 1445.5%Free Cash Flow
↓ 411406674.2%Diluted EPS
No data
Quick Stats
Open
$19.53
Day High
$19.92
Day Low
$19.36
Prev Close
$19.73
Market Cap
—
Volume
80,949
Tekla Life Sciences Investors (HQL) analysis
Wrqti brings Tekla Life Sciences Investors data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$19.84
Market cap
$553.12M
PE ratio
3.35
Price to book
1.12
Profit margin
505.41%
FCF yield
—
Stocks related to Tekla Life Sciences Investors
Companies in the same sector you can compare with Tekla Life Sciences Investors: